Event
Neuralink reports PRIME Study progress after first human implant
Key points
- Neuralink published a progress update on the PRIME Study after the first human implantation.
- The company said the participant was using the implant to control a computer cursor and digital interfaces.
- Neuralink also disclosed that some implant threads had retracted from the brain, reducing electrode effectiveness and prompting software and signal-processing changes.
Company context
Neuralink is a neurotechnology company developing implantable brain-computer interfaces for people with unmet medical needs, beginning with device control for people with paralysis. Its system combines the N1 Implant, external software, wireless communication, and the R1 surgical robot used to place ultra-fine electrode threads in the brain.
Context
- Company
- Neuralink
- Segment
- Healthcare
- Event type
- Capability
- Geography
- Fremont · United States